0001209191-23-011293.txt : 20230221
0001209191-23-011293.hdr.sgml : 20230221
20230221172343
ACCESSION NUMBER: 0001209191-23-011293
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230216
FILED AS OF DATE: 20230221
DATE AS OF CHANGE: 20230221
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Novack David F
CENTRAL INDEX KEY: 0001573072
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34207
FILM NUMBER: 23649525
MAIL ADDRESS:
STREET 1: 39 YORKSHIRE DR
CITY: OAKLAND
STATE: CA
ZIP: 94618
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DYNAVAX TECHNOLOGIES CORP
CENTRAL INDEX KEY: 0001029142
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 330728374
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2100 POWELL STREET
STREET 2: SUITE 720
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: 5108485100
MAIL ADDRESS:
STREET 1: 2100 POWELL STREET
STREET 2: SUITE 720
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-02-16
0
0001029142
DYNAVAX TECHNOLOGIES CORP
DVAX
0001573072
Novack David F
C/O DYNAVAX TECHNOLOGIES
2100 POWELL STREET, SUITE 720
EMERYVILLE
CA
94608
0
1
0
0
President & COO
Common Stock
2023-02-15
4
A
0
1121
9.73
A
3187
D
Stock Option (Right to Buy)
11.12
2023-02-16
4
A
0
150000
A
2030-02-15
Common Stock
150000
150000
D
Includes 1,121 shares acquired under issuer's 2014 Employee Stock Purchase Plan (ESPP) on February 15, 2023
This option grant will vest over three (3) years with one third (1/3) of the shares subject to the option vesting twelve months after the grant date of February 16, 2023, and one thirty-sixth (1/36) of the shares subject to the option vesting each month thereafter.
/s/ David Novack
2023-02-21